Brief: Vaxart Completes Enrollment Of Sentinel Cohort In Phase 2B Study
02/12/2024 21:06
Dec 2 (Reuters) - Vaxart Inc VXRT.O :
* VAXART COMPLETES ENROLLMENT OF SENTINEL COHORT IN PHASE 2B
STUDY
EVALUATING ITS COVID-19 ORAL PILL VACCINE CANDIDATE
Source text: ID:nGNX3l8VsX
Further company coverage: VXRT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vaxart
See all newsBrief: Vaxart Expands Intellectual Property Portfolio With European Patent Protecting Proprietary Norovirus Vaccine Technology
Vaxart Q2 revenue falls on lower government contract income
Brief: Vaxart Q2 Net Income USD -13.494 Million
Brief: Vaxart Enters Cooperation Agreement With Stockholder Group And Announces Board And Corporate Governance Enhancements
Vaxart Q1 revenue more than doubles on government contracts